Prof. Juergen Scheele, Chief Medical Officer, Innoplexus highlights that healthcare professionals must come together to ensure that licensing of biospecimens for cancer research follows the highest ethical standards and is used for drug discovery and exploring new avenues in cancer prevention, treatment, and control.
Healthcare professionals must come together to ensure that licensing of biospecimens for cancer research follows the highest ethical standards and is used for drug discovery and exploring new avenues in cancer prevention, treatment, and control. Timely sharing of electronic health records across providers while ensuring data security and privacy is essential for prompt care of cancer patients and enhancing medical research and precision medicine.
Intelligent data management and AI-led data-sharing practices are being touted as possible solutions to some of these challenges. The use of blockchain technology has been recently advocated by research communities and is gaining momentum from the industry perspective. Hopefully, advancements in data-sharing processes can end long-standing ethical issues and create a protection framework for research with human subjects!
Click to read more.